Skip to main content

Cornerstone Innovation

Cornerstone Innovation offers AIDA (Artificial Intelligence Drug Assistant), a system that instantly identifies any FDA-approved drug and automatically prints a compliant medication label. AIDA eliminates handwritten labels by generating drug-class-specific color and format standards, including Tall Man lettering to differentiate look-alike, sound-alike drugs, and produces tear- and water-resistant labels. The system also verifies expiration dates and checks for drug recalls, and is currently undergoing field trials as the company's first product.

Traction –/10
Santa Fe, United States · HQ
5+ followers
  • Healthcare Technology
  • Digital Health
  • Artificial Intelligence
  • Regulatory & Compliance Technology
  • Software Only
Updated 12 days ago

Funding

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Medical providers frequently hand-write medication labels, a process that is time-consuming and prone to errors in drug identification, dosage specification, and labeling compliance. Labels must meet strict regulatory standards from organizations like The Joint Commission, the United States Pharmacopoeia, and ASTM, while also addressing patient safety risks from look-alike, sound-alike drug names.

Solution

Cornerstone Innovation offers AIDA (Artificial Intelligence Drug Assistant), a system that instantly identifies any FDA-approved drug and automatically prints a compliant medication label. AIDA removes the need for handwritten labels by generating labels that meet the specific color and format standards for each drug class, include required information such as drug name, dosage, date, time, and initials, and apply Tall Man lettering to differentiate commonly confused drugs. The solution produces tear- and water-resistant labels that are easy to apply, streamlining the medication preparation workflow for providers. AIDA also verifies expiration dates and checks for drug recalls as part of its functionality. AIDA is currently undergoing field trials as the company's first product.

Target Audience

Primary users are medical providers, including hospitals, clinics, and pharmacists, who prepare medication labels and need to ensure regulatory compliance and patient safety.

Features

  • Automatic identification of any FDA-approved drug
  • Label generation compliant with Joint Commission, United States Pharmacopoeia, and ASTM guidelines
  • Drug-class-specific color and format standards
  • Tall Man lettering for look-alike, sound-alike drug differentiation
  • Tear- and water-resistant label material
  • Expiration date verification and drug recall checking capabilities
This profile is AI-generated and may contain inaccuracies.